Telesis Bio, Inc. (NASDAQ:TBIO) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q2, 2023 Telesis Bio Earnings Conference Call. At this time, all participants are in listen-only mode.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Millennium Management Israel Englander | 0 | $0 | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.56 | 122,516 | Large Shareholder, Officer, Director | 122,516 | 2022-11-11 | Filing | |
$16.00 | 468,750 | Large Shareholder | 9,844,130 | 2021-06-22 | Filing | |
$18.25 | 500 | Officer | 500 | 2021-06-18 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$2.83 | 2,575 | Large Shareholder, Officer, Director | 136,072 | 2023-05-04 | Filing | |
$2.83 | 1,190 | Officer | 102,083 | 2023-05-04 | Filing | |
$2.83 | 1,174 | Officer | 25,468 | 2023-05-04 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 46,600 | $178 | 0% | |
2. | 0 | $0 | 0% | |
3. | 0 | $0 | 0% | |
4. | 0 | $0 | 0% | |
5. | 0 | $0 | 0% |